Endotronix, Inc.: Endotronix Announces Positive Data from SIRONA 2 in Late-Breaking Clinical Trial Session

Study met all primary safety and efficacy endpoints for the Cordella PA Pressure Sensor System for the treatment of NYHA class III heart failure patients LISLE, Ill., May 23, 2022

Related Keywords

Spain ,Germany ,Genk ,Region Flamande ,Belgium ,Ireland ,Hasselt ,Madrid ,Carla Benigni ,Katrin Leadley ,Kostenloser Wertpapierhandel ,University Hasselt ,Heart Failure Association ,Prnewswire Endotronix Inc ,York Heart Association ,Endotronix Inc ,European Society Of Cardiology ,Sensor System ,Cordella Pulmonary Artery Pressure Sensor System ,Cordella Sensor ,New York Heart Association ,European Society ,Cordella Heart Failure System ,Wilfried Mullens ,Hospital Oost Limburg ,Chief Medical Officer ,Cordella System ,Endotronix ,Nnounces ,Positive ,Data ,Rom ,Sirona ,Gate ,Breaking ,Linical ,Trial ,Session ,